文献速递功能神经外科

磁共振引导聚焦超声丘脑毁损术治疗特发性震颤:5年单中心经验

Magnetic resonance-guided focused ultrasound thalamotomy for essential tremor: a 5-year single-center experience.
PubMed 文献 · J Neurosurg · 2019-07-05

该单中心研究评估了44例药物难治性特发性震颤患者接受单侧磁共振引导聚焦超声(MRgFUS)丘脑腹中间核(VIM)毁损术的5年疗效与安全性。结果显示震颤即刻显著改善,CRST和QUEST评分长期维持改善,11%患者震颤复发影响日常生活,11%患者不良事件未完全恢复。作者认为该技术有效且安全,但需更大样本研究证实。

要点

  • MRgFUS丘脑毁损术可即刻显著改善药物难治性特发性震颤,并长期维持疗效。
  • 5年内11%患者震颤复发影响日常生活,11%患者不良事件未完全恢复。
  • 生活质量(QUEST评分)在5年随访中持续显著改善。

核心结论

  • MRgFUS丘脑毁损术治疗特发性震颤有效且安全,可提供长期震颤缓解和生活质量改善。
  • 需更大样本研究进一步证实这些有利结果。

研究设计与样本

  • 单中心5年随访研究,纳入44例药物难治性特发性震颤患者,接受单侧MRgFUS VIM丘脑毁损术。
  • 采用CRST评分和QUEST问卷在5年期间评估疗效。

主要发现

  • 所有患者术后震颤即刻改善,24例完全停止。
  • 治疗手CRST评分基线中位数19(范围7-32,44例),1个月改善中位数16(44例,p<0.0001),6个月17(31例,p<0.0001),1年15(24例,p<0.0001),2年18(15例,p<0.0001),3年19(10例,p<0.0001),4年21(6例,p<0.01),5年23(2例,未检验显著性)。
  • 5例(11%)报告震颤复发影响日常生活。
  • QUEST评分1个月中位变化35分(p<0.0001,44例),6个月33(p<0.0001,31例),1年27(p<0.0001,24例),2年26(p<0.001,15例),3年25(p<0.001,10例),4年33(p<0.001,6例),5年28(未检验显著性,2例)。
  • 不良事件除5例(11%)外均为可逆。

临床怎么用

  • 对于药物难治性特发性震颤,MRgFUS丘脑毁损术可作为有效且安全的治疗选择。
  • 术后需长期随访震颤复发和不良事件恢复情况。

局限性

  • 单中心研究,样本量较小,随随访时间延长评估病例数显著减少(5年仅2例)。
  • 5年数据未进行显著性检验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The authors report their experience in treating patients suffering from medication-resistant essential tremor (ET) with MR-guided focused ultrasound (MRgFUS) thalamotomy over a 5-year period. METHODS: Forty-four ET patients treated with unilateral MRgFUS ventral intermediate nucleus (VIM) thalamotomy were assessed using the Clinical Rating Scale for Tremor (CRST) score and the Quality of Life in Essential Tremor Questionnaire (QUEST) over a 5-year span. RESULTS: Tremor was significantly improved immediately following MRgFUS in all patients and ceased completely in 24 patients. CRST scores in the treated hand at baseline (median 19; range 7-32, 44 patients) improved by a median of 16 at 1 month (44 patients; p < 0.0001), 17 at 6 months (31 patients; p < 0.0001), 15 at 1 year (24 patients; p < 0.0001), 18 at 2 years (15 patients; p < 0.0001), 19 at 3 years, (10 patients; p < 0.0001), 21 at 4 years (6 patients; p < 0.01), and 23 at 5 years (2 patients, significance not tested). Return of tremor that impacted activities of daily living was reported in 5 patients (11%). QUEST scores showed significant improvement, with median change of 35 points (p < 0.0001; 44 patients) at 1 month, 33 (p < 0.0001; 31 patients) at 6 months, 27 (p < 0.0001; 24 patients) at 1 year, 26 (p < 0.001; 15 patients) at 2 years, 25 (p < 0.001; 10 patients) at 3 years, 33 (p < 0.001; 6 patients) at 4 years, and 28 (significance not tested, 2 patients) at 5 years. Adverse events after the procedure were reversible in all but 5 patients (11%). CONCLUSIONS: MRgFUS thalamotomy for ET is an effective and safe procedure that provides long-term tremor relief and improvement in quality of life even in patients with medication-resistant disabling tremor. Additional studies with a larger group of patients is needed to substantiate these favorable results.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Sinai A, Nassar M, Eran A, et al. Magnetic resonance-guided focused ultrasound thalamotomy for essential tremor: a 5-year single-center experience. J Neurosurg. 2019. PMID: 31277064. doi:10.3171/2019.3.JNS19466

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。